Notre Dame Intermedica Participacoes SA
OTC:NTEDY
Intrinsic Value
Notre Dame Intermédica Participações SA provides healthcare plans and medical services. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of NTEDY.
Notre Dame Intermedica Participacoes SA's market capitalization is 6.4B USD.
NTEDY stock price is 10.5001 USD.
NTEDY.
NTEDY. Open DCF Valuation
NTEDY. Open Relative Valuation
NTEDY.
NTEDY's ROIC (Return on Invested Capital) has increased in the last 3 years from 7% to 8%.
NTEDY's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 8%.
NTEDY has positive Operating Income for the last twelve months.
NTEDY has positive three-year average ROE (Return on Equity): 12%. The company is efficient at transforming stockholders' equity into net income.
NTEDY's ROE (Return on Equity) for the past 12 months is positive and is equal to 15%.
NTEDY's ROE (Return on Equity) has increased in the last 3 years from 10% to 15%.
NTEDY has positive Net Income for the last twelve months.
NTEDY has positive three-year average ROIC (Return on Invested Capital): 7%. The company is efficient at using invested capital to generate operating income.
NTEDY has positive Free Cash Flow for the last twelve months.
NTEDY has negative Net Debt. This means that the company has more cash and short-term investments (3B BRL) than debt (3B BRL).
NTEDY's short-term assets (5B BRL) exceed its short-term liabilties (3B BRL).
NTEDY's Revenue is forecast to grow at a rate of 23% per year over the next 3 years.
NTEDY has positive Gross Profit for the last twelve months.
NTEDY generates enough operating income (1B BRL) to cover interest payments on its debt (151m BRL).
NTEDY's long-term assets (16B BRL) exceed its long-term liabilties (9B BRL).
NTEDY's D/E (Debt to Equity) is very low and is equal to 0.41.
NTEDY's Altman Z-Score is very low and is equal to 0.96.
Fundamental Analysis
Notre Dame Intermedica Participacoes SA
Balance Sheet Decomposition
Notre Dame Intermedica Participacoes SA
| Current Assets | 4.8B |
| Cash & Short-Term Investments | 3B |
| Receivables | 1.3B |
| Other Current Assets | 549.1m |
| Non-Current Assets | 11B |
| Long-Term Investments | 152.3m |
| PP&E | 2.6B |
| Intangibles | 802.6m |
| Other Non-Current Assets | 7.5B |
| Current Liabilities | 3.1B |
| Accounts Payable | 124.5m |
| Accrued Liabilities | 349.1m |
| Other Current Liabilities | 2.6B |
| Non-Current Liabilities | 5.7B |
| Long-Term Debt | 2.9B |
| Other Non-Current Liabilities | 2.7B |
Earnings Waterfall
Notre Dame Intermedica Participacoes SA
|
Revenue
|
10.2B
BRL
|
|
Cost of Revenue
|
-7.1B
BRL
|
|
Gross Profit
|
3B
BRL
|
|
Operating Expenses
|
-1.7B
BRL
|
|
Operating Income
|
1.4B
BRL
|
|
Other Expenses
|
-657.4m
BRL
|
|
Net Income
|
712.6m
BRL
|
Free Cash Flow Analysis
Notre Dame Intermedica Participacoes SA
NTEDY Profitability Score
Profitability Due Diligence
Notre Dame Intermedica Participacoes SA's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Notre Dame Intermedica Participacoes SA's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
NTEDY Solvency Score
Solvency Due Diligence
Notre Dame Intermedica Participacoes SA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Notre Dame Intermedica Participacoes SA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NTEDY Price Targets Summary
Notre Dame Intermedica Participacoes SA
Shareholder Return
NTEDY Price
Notre Dame Intermedica Participacoes SA
| Average Annual Return | 29.09% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -49% |
| Market Capitalization | 6.4B USD |
| Shares Outstanding | 619 952 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Notre Dame Intermedica Participacoes SA
Country
Industry
Market Cap
Dividend Yield
Description
Notre Dame Intermédica Participações SA provides healthcare plans and medical services. The company is headquartered in Sao Paulo, Sao Paulo and currently employs 11,032 full-time employees. The company went IPO on 2018-04-23. The firm operates as the holding company of the NotreDame Intermedica Group. Notre Dame has offices in Sao Paulo, Rio de Janeiro, Jundai, Campinas, Sorocaba and Baixada Santista and through its subsidiaries offers different medical services in Brazil. The firm owns more than 15 hospitals, more than 20 emergency rooms, more than 10 units of preventive medicine and more than 65 clinical centers. Notre Dame through its subsidiaries offers health services; dental services, which includes dental plans, preventive dentistry and online contact, and other specialized services as child surgery or occupational health.
You don't have any saved screeners yet
